United States · FDA National Drug Code directory
Renvela
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 58468-0131_cb4453a2-c47b-4352-839f-f022ac67368e
- Product NDC
- 58468-0131
- Form
- POWDER, FOR SUSPENSION
- Composition / generic term
- SEVELAMER CARBONATE
- Labeler
- Genzyme Corporation
- Marketing category
- NDA
- Marketing start / end (source format)
- 20090812
- Source listing expiry
- 20261231
Source-listed ingredients
- SEVELAMER CARBONATE — 2400 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 90 PACKET in 1 CARTON (58468-0131-2) / 1 POWDER, FOR SUSPENSION in 1 PACKET (58468-0131-1) · 58468-0131-2
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →